Litcius/Paper detail

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial

Étienne Brain, Olivier Mir, Emmanuelle Bourbouloux, Olivier Rigal, Jean-Marc Ferrero, Sylvie Kirscher, Djelila Allouache, Véronique D’Hondt, Aude-Marie Savoye, Xavier Durando, François P. Duhoux, Laurence Venat‐Bouvet, Emmanuel Blot, Jean-Luc Canon, Florence Rollot-Trad, Hervé Bonnefoi, Telma Roque, Jérôme Lemonnier, Aurélien Latouche, Julie Henriques, Magali Lacroix‐Triki, Déwi Vernerey, Étienne Brain, Olivier Mir, Emmanuelle Bourbouloux, Jean-­Marc Ferrero, O. Rigal, Sylvie Kirscher, Djelila Allouache, Sophie Abadie‐Lacourtoisie, Paul Cottu, Gilles Romieu, Xavier Durando, Aude-Marie Savoye, FP Duhoux, Laurence Venat‐Bouvet, Emmanuelle Malaurie, Emmanuel Blot, Sylvain Ladoire, C. Terret, Jean-Luc Canon, V. Servent, Loı̈c Mourey, Véronique SERVENT, E. Carola, Lionel Uwer, Véronique Girre, Pierre Guillet, Marc Debled, Lucie Monceau-Baroux, Jean‐Claude Darmon, Francesco Del Piano, L. Joly, Hugues Bourgeois, Valérie Delecroix, Frédérique Rousseau, Jean-Philippe Jacquin, Thierry Petit, Emmanuel Blot, Laëtitia Stefani, Claire Falandry, Oana Cojocarasu, Anne Mercier-Blas, C.R. Alliot, Heba Dawood, Éric Raymond, Heba DAWOOD, C. Tournigand, Bénédicte PETIT, Jean-François Berdah, M.H. Baron, Peter Vuylsteke, Marie-Pascale Graas, Philippe Houyau, Philippe Glorieux, Annelore Barbeaux, Victor Simmet, Jérôme Dauba, Frédéric Forget, Jean‐Emmanuel Kurtz, Lionel Duck, Guillermo REYES ORTEGA, S. Barthier, Lionel D’Hondt, Etienne Suc, Chantal BERNARD-MARTY, Laurent Cany, Nadia Raban, G Des Guetz, J. Ayllón, Vincent Richard, J. Ayllón, Vincent Richard

2025The Lancet14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdjuvantBreast cancerOncologyInternal medicineAdjuvant chemotherapyChemotherapyCancerGynecologyBreast Cancer Treatment StudiesCancer Risks and FactorsBreast Lesions and Carcinomas
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial | Litcius